Costes intangibles de la dependencia alcohólica desde la perspectiva de los pacientes y sus familiaresun estudio de valoración contingente

  1. Jacinto Mosquera Nogueira 1
  2. Eva Rodríguez-Míguez 2
  1. 1 Alcohol Unit of Vigo
  2. 2 Departament of Applied Economics. University of Vigo
Revista:
Adicciones: Revista de socidrogalcohol

ISSN: 0214-4840

Año de publicación: 2018

Volumen: 30

Número: 2

Páginas: 111-122

Tipo: Artículo

DOI: 10.20882/ADICCIONES.851 DIALNET GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: Adicciones: Revista de socidrogalcohol

Objetivos de desarrollo sostenible

Resumen

Alcohol dependence causes multiple problems not only for the person suffering dependence but also for others. In this study, the contingent valuation method is proposed to measure the intangible effects of alcohol dependence from the perspective of the persons directly involved: the patients and their relatives. Interviews were conducted with 145 patients and 61 relatives. Intangible effects of alcohol dependence were determined based on willingness to pay for a hypothetical treatment for dependence, with different success scenarios (50% and 100%). The mean monthly willingness to pay among the alcohol-dependent population was €129 and €168, respectively, for the treatments with 50% and 100% success. The willingness to pay of relatives was greater in both scenarios (€307 and €420, respectively), which could be explained by their greater perception of the family, labour, and health problems resulting from alcohol dependence. Regression analysis showed that patients’ willingness to pay is positively related to treatment efficacy, personal income and moderate health deterioration, and negatively related to feeling discouraged and depressed. The results from this study can be applied to economic valuation studies that aim to measure the benefits of programs intended to reduce the prevalence of alcohol dependence. The intangible costs estimated can be added to the direct and indirect costs commonly used.

€ Ver financiación

Información de financiación

We appreciate the help given by the employees of Alcohol Unit of Vigo in the recruitment of patients. We are also particularly grateful to all the patients and their families for their contribution to this study. Financial support from Spanish Ministry of Science and Innovation (ECO2015-69334-R) and Regional Government of Galicia (10SEC300038PR and ECOBAS [AGRUP2015/08]) is gratefully acknowledged.

Financiadores

Referencias bibliográficas

  • Amin, M. y Khondoker, F. (2004). A contingent valuation study to estimate the parental willingness-to-pay for childhood diarrhea and gender bias among rural households in India. Health Research Policy and Systems, 2, 1359-1386. doi:10.1186/1478-4505-2-3.
  • Anderson, P. y Baumberg, B. (2006). Alcohol in Europe. London: Institute of Alcohol Studies. Recuperado de http:// ec.europa.eu/health-eu/news_alcoholineurope_en.htm.
  • Arrow, K., Solow, R., Portney, P. R., Leamer, E. E., Radner, R. y Schuman, H. (1993). Report of the NOAA Panel on Contingent Valuation. Federal Register 58, 4602–4614.
  • Baumberg, B. (2010). Best practice in estimating the costs of alcohol–Recommendations for future studies. WHO Regional Office for Europe. Recuperado de http://www.euro.who. int/_data/assets/pdf_file/0009/112896/E93197.pdf .
  • Bergmo, T. S. y Wangberg, S. C. (2007). Patients’ willingness to pay for electronic communication with their general practitioner. The European Journal of Health Economics, 8, 105-110. doi:10.1007/s10198-006-0014-5.
  • Bishai, D., Sindelar, J., Ricketts, E. P., Huettner, S., Cornelius, L., Lloyd, J. J., ... Strathdee, S. A. (2008). Willingness to pay for drug rehabilitation: implications for cost recovery. Journal of Health Economics, 27, 959-972. doi:10.1016/j.jhealeco.2007.11.007.
  • Blumenschein, K., Johannesson, M., Yokoyama, K. y Freeman, P. (2001). Hypothetical versus real willingness to pay in the health care sector: results from a field experiment. Value in Health, 4, 79-79. doi:10.1046/j.15244733.2001.40202-36.x.
  • Boonen, A., Severens, J. L., Van Tubergen, A., Landewé, R., Bonsel, G., Van der Heijde, D. y van der Linden, S. (2005). Willingness of patients with ankylosing spondylitis to pay for inpatient treatment is influenced by the treatment environment and expectations of improvement. Annals of the Rheumatic Diseases, 64, 1650-1652. doi:10.1136/ard.2005.038786.
  • Brazier, J., Akehurst, R., Brennan, A., Dolan, P., Claxton, K., McCabe, C., ... Tsuchyia, A. (2005). Should patients have a greater role in valuing health states?. Applied Health Economics and Health Policy, 4, 201-208. doi:10.2165/00148365-200504040-00002.
  • Burling, T. A., Reilly, P. M., Moltzen, J. O. y Ziff, D. C. (1989). Self-efficacy and relapse among inpatient drug and alcohol abusers: a predictor of outcome. Journal of Studies on Alcohol, 50, 354-360. doi:10.15288/jsa.1989.50.354.
  • Byrne, M. M., O’Malley, K. y Suarez-Almazor, M. E. (2005). Willingness to pay per quality-adjusted life year in a study of knee osteoarthritis. Medical Decision Making, 25, 655-666. doi:10.1177/0272989X05282638.
  • Carson, R. T. y Hanemann, W. M. (2005). Contingent Valuation. In K. G. Maler & J. R. Vincent (Eds.), the Handbook of Environmental Economics: Valuing Environmental Changes (Vol. 2), pp 821-920. Elsevier.
  • Chisholm, D., Rehm, J., Van Ommeren, M. y Monteiro, M. (2004). Reducing the global burden of hazardous alcohol use: a comparative cost-effectiveness analysis. Journal of Studies on Alcohol, 65, 782-793. doi:10.15288/ jsa.2004.65.782.
  • Collins, D. J. y Lapsley, H. M. (2008). The avoidable costs of alcohol abuse in Australia and the potential benefits of effective policies to reduce the social costs of alcohol (pp. 1-51). Australian Government Department of Health & Ageing. Recuperado de http://www.nationaldrugstrategy.gov.au/internet/drugstrategy/publishing.nsf/content/mono70.
  • Corry, J., Sanderson, K., Issakidis, C., Andrews, G. y Lapsley, H. (2004). Evidence-based care for alcohol use disorders is affordable. Journal of Studies on Alcohol. 65, 521–529. doi:10.15288/jsa.2004.65.521.
  • Diamond, P. A. y Hausman, J. A. (1994). Contingent valuation: Is some number better than no number?. The Journal of Economic Perspectives, 8, 45-64. doi:10.1257/ jep.8.4.45.
  • Donaldson, C., Thomas, R. y Torgerson, D. J. (1997). Validity of open-ended and payment scale approaches to eliciting willingness to pay. Applied Economics, 29, 79-84. doi:10.1080/000368497327425.
  • Fautrel, B., Clarke, A. E., Guillemin, F., Adam, V., St-Pierre, Y., Panaritis, T., ... Penrod, J. R. (2007). Costs of rheumatoid arthritis: new estimates from the human capital method and comparison to the willingness-to-pay method. Medical Decision Making, 27, 138-150. doi:10.1016/j. healthpol.2008.12.011.
  • Fernández, A., Saameño, J. Á. B., Pinto-Meza, A., Luciano, J. V., Autonell, J., Palao, D., ... Serrano, A. (2010). Burden of chronic physical conditions and mental disorders in primary care. The British Journal of Psychiatry, 196, 302309. doi:10.1192/bjp.bp.109.074211.
  • Gabriel, S. E., Kneeland, T. S., Melton, L. J., Moncur, M. M., Ettinger, B. y Tosteson, A. N. (1999). Health-related Quality of Life in Economic Evaluations for Osteoporosis Whose Values Should We Use?. Medical Decision Making, 19, 141-148. doi:10.1007/s00198-008-0743-7.
  • García-Pérez, L., Aguiar-Ibáñez, R., Pinilla-Domínguez, P., Arvelo-Martín, A., Linertová, R. y Rivero-Santana, A. (2014). Revisión sistemática de utilidades relacionadas con la salud en España: el caso de la salud mental. Gaceta Sanitaria, 28, 77-83.
  • Grandes, G., Montoya, I., Arietaleanizbeaskoa, M. S., Arce, V. y Sanchez, A. (2011). The burden of mental disorders in primary care. European Psychiatry, 26, 428-435.
  • Greenberg, D., Bakhai, A., Neumann, P. J. y Cohen, D. J. (2004). Willingness to pay for avoiding coronary restenosis and repeat revascularization: results from a contingent valuation study. Health Policy, 70, 207-216. doi:10.1016/j.healthpol.2004.03.002.
  • Gueylard-Chenevier, D. G. y LeLorier, J. (2005). A willingness-to-pay assessment of parents’ preference for shorter duration treatment of acute otitis media in children. Pharmacoeconomics, 23, 1243-1255. doi:10.1186/14777525-8-75.
  • Gyrd-Hansen, D., Jensen, M. L. y Kjaer, T. (2014). Framing the willingness-to-pay question: Impact on response patterns and mean willingness to pay. Health Economics, 23, 550-563. doi:10.1002/hec.2932.
  • He, M., Chan, V., Baruwa, E., Gilbert, D., Frick, K. D. y Congdon, N. (2007). Willingness to pay for cataract surgery in rural Southern China. Ophthalmology 114, 411–416. doi:10.1016/j.ophtha.2006.09.012.
  • Jarl, J., Johansson, P., Eriksson, A., Eriksson, M., Gerdtham, U. G., Hemström, Ö., ... Room, R. (2008). The societal cost of alcohol consumption: an estimation of the economic and human cost including health effects in Sweden, 2002. The European Journal of Health Economics, 9, 351-360. doi:10.1007/S10198-007-0082-1
  • Jeanrenaud, C. y Pellegrini, S. (2007). Valuing intangible costs of alcohol dependence: A contingent valuation study. Revue d’Economie Politique, 117, 813-825. doi:10.3917/redp.175.0813.
  • Jimoh, A., Sofola, O., Petu, A. y Okorosobo, T. (2007). Quantifying the economic burden of malaria in Nigeria using the willingness to pay approach. Cost Effectiveness and Resource Allocation, 5, 1. doi:10.1186/1478-7547-5-6.
  • Johansson, P., Jarl, J., Eriksson, A., Eriksson, M., Gerdtham, U. G., Hemström, Ö., ... Room, R. (2006). The social costs of alcohol in Sweden 2002. Stockholms Universitet, Centrum för socialvetenskaplig alkohol-och drogforskning (SoRAD). doi:10.1007/S10198-007-0082-1.
  • John, U., Rumpf, H. J., Bischof, G., Hapke, U., Hanke, M. y Meyer, C. (2013). Excess Mortality of Alcohol-Dependent Individuals After 14 Years and Mortality Predictors Based on Treatment Participation and Severity of Alcohol Dependence. Alcoholism: Clinical and Experimental Research, 37, 156-163. doi:10.1111/j.1530-0277.2012.01863.x.
  • Kraemer, K. L., Roberts, M. S., Horton, N. J., Palfai, T., Samet, J. H., Freedner, N., ... Saitz, R. (2005). Health utility ratings for a spectrum of alcohol-related health states. Medical Care, 43, 541-550. doi:10.1097/01. mlr.0000163644.97251.14.
  • Laslett, A. M., Catalano, P., Chikritzhs, T., Dale, C., Doran, C., Ferris, J., ... Room, R. (2010). The range and magnitude of alcohol’s harm to others. AER Centre for Alcohol Policy Research, Turning Point Alcohol and Drug Centre, Eastern Health: Fitzroy, Victoria.
  • Maheswaran, H., Petrou, S., Rees, K. y Stranges, S. (2013). Estimating EQ-5D utility values for major health behavioural risk factors in England. Journal of Epidemiology and Community Health, 67, 172-180. doi:10.1136/jech-2012201019.
  • Mann, R., Brazier, J. y Tsuchiya, A. (2009). A comparison of patient and general population weightings of EQ-5D dimensions. Health Economics, 18, 363-372. doi:10.1002/ hec.1362.
  • Mortimer, D. y Segal, L. (2005). Economic evaluation of interventions for problem drinking and alcohol dependence: cost per QALY estimates. Alcohol and Alcoholism, 40, 549-555. doi:10.1093/alcalc/agh192
  • Mosquera J. y Rodríguez-Míguez, E. (2015). Using the SF6D to measure the impact of alcohol dependence on health-related quality of life. The European Journal of Health Economics, 16, 347-356. doi:10.1007/s10198-014-0627-z.
  • Navarro, H. J., Doran, C. M. y Shakeshaft, A. P. (2011). Measuring costs of alcohol harm to others: A review of the literature. Drug and alcohol dependence, 114, 87-99. doi:10.1016/j.drugalcdep.2010.11.009.
  • Neumann, P. J. y Johannesson, M. (1994). The willingness to pay for in vitro fertilization: a pilot study using contingent valuation. Medical Care, 32, 686-699. doi:10.1186/14726963-8-261.
  • Nutt, D. J., King, L. A. y Phillips, L. D. (2010). Drug harms in the UK: a multicriteria decision analysis. The Lancet, 376, 1558-1565. doi:10.1016/S0140-6736(10)61462-6.
  • Parrott, S., Godfrey, C., Heather, N., Clark, J. y Ryan, T. (2006). Cost and outcome analysis of two alcohol detoxification services. Alcohol and Alcoholism, 4, 84-91 doi:10.1093/alcalc/agh236.
  • Petersen, S., Peto, V., Rayner, M., Leal, J., Luengo-Fernández, R. y Gray, A. (2005). European cardiovascular disease statistics: 2005 edition. (pp 70-72). British Heart Foundation. Department of Public Health, University of Oxford.
  • Petrie, D., Doran, C. y Shakeshaft, A. (2011). Willingness to pay to reduce alcohol-related harm in Australian rural communities. Expert Review of Pharmacoeconomics & Outcomes Research, 11, 351-363. doi:10.1586/erp.11.28.
  • Petrie, D., Doran, C., Shakeshaft, A. y Sanson-Fisher, R. (2008). The relationship between alcohol consumption and self-reported health status using the EQ5D: evidence from rural Australia. Social Science & Medicine, 67, 17171726. doi:10.1016/j.socscimed.2008.09.017 .
  • Pinto-Prades, J. L., Farreras, V. y de Bobadilla, J. F. (2008). Willingness to pay for a reduction in mortality risk after a myocardial infarction: an application of the contingent valuation method to the case of eplerenone. The European Journal of Health Economics, 9, 69-78. doi:10.1007/sl0198007-0041-x.
  • Rehm, J., Room, R., Monteiro, M., Gmel, G., Graham, K., Rehn, T.,... Jernigan, D. (2004). Comparative quantification of health risks: global and regional burden of disease due to selected major risk factors, World Health Organization. Retrieved at: www.who.int/publications/cra/ chapters/volume1/0959-1108.pdf.
  • Rehm, J., Rehm, M., Shield, K., Gmel, G. y Gual, T. (2013). Alcohol consumption, alcohol dependence and related harms in Spain, and the effect of treatment-based interventions on alcohol dependence. Adicciones, 25, 11-18.. doi:10.1186/1747-597X-8-21.
  • Saarni, S. I., Suvisaari, J., Sintonen, H., Pirkola, S., Koskinen, S., Aromaa, A. y Lönnqwist, J. (2007). Impact of psychiatric disorders on health-related quality of life: general population survey. The British Journal of Psychiatry, 190, 326-332. doi:10.1016/j.comppsych.2008.06.003.
  • Sadri, H., MacKeigan, L. D., Leiter, L. A. y Einarson, T. R. (2005). Willingness to pay for inhaled insulin. Pharmacoeconomics, 23, 1215-1227. doi:10.1016/j.sapharm.2008. 10.001.
  • Sanderson, K., Andrews, G., Corry, J. y Lapsley, H. (2004). Using the effect size to model change in preference values from descriptive health status. Quality of Life Research, 13, 1255-1264. doi:10.1023/B:QURE.0000037482.92757.82.
  • Smith, R. D. (2003). Construction of the contingent valuation market in health care: a critical assessment. Health Economics, 12, 609-628. doi:10.1002/hec.755.
  • Stouthard, M. E., Essink-Bot, M. L. y Bonsel, G. L. (2000). Disability weights for diseases: a modified protocol and results for a Western European region. The European Journal of Public Health, 10, 24-30. doi:10.1093/eurpub/10.1.24 24-30.
  • Tang, C. H., Liu, J. T., Chang, C. W. y Chang, W. Y. (2007). Willingness to pay for drug abuse treatment: results from a contingent valuation study in Taiwan. Health Policy, 82, 251-262. doi:10.1016/j.healthpol.2006.09.007.
  • Ubel, P. A., Loewenstein, G. y Jepson, C. (2003). Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public. Quality of Life Research, 12, 599-607. doi:10.1023/A:1025119931010.
  • UKATT Research Team. (2005). Cost effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT). The British Medical Journal, 331, 544. doi:10.1093/alcalc/agn112.
  • Unützer, J., Katon, W. J., Russo, J., Simon, G., Von Korff, M., Lin, E., ... Bush, T. (2003). Willingness to pay for depression treatment in primary care. Psychiatric Services, 54, 340–345. doi:10.1176/ps.54.3.340.
  • Viscusi, W. K., Magat, W. A. y Huber, J. (1987). An investigation of the rationality of consumer valuations of multiple health risks. The RAND Journal of Economics, 18, 465-479.
  • Walsh, B. M. y Bartfield, J. M. (2006). Survey of parental willingness to pay and willingness to stay for” painless” intravenous catheter placement. Pediatric Emergency Care, 22, 699-703. doi:10.1097/01.pec.0000238743.96606.69.
  • Whynes, D. K., Frew, E. y Wolstenholme, J. L. (2003). A comparison of two methods for eliciting contingent valuations of colorectal cancer screening. Journal of Health Economics, 22, 555-574. doi:10.1016/S0167-6296(03)00006-7.
  • Yasunaga, H., Ide, H., Imamura, T. y Ohe, K. (2006). Benefit evaluation of mass screening for prostate cancer: willingness-to-pay measurement using contingent valuation. Urology, 68, 1046-1050. doi:10.1111/j.14422042.2009.02293.x.
  • Zarkin, G. A., Cates, S. C. y Bala, M. V. (2000). Estimating the willingness to pay for drug abuse treatment: A pilot study. Journal of Substance Abuse Treatment, 18, 149-159. doi:10.1016/S0740-5472(99)00030-6.
Fuente de los datos: Dialnet